NEWS. Sciety has contributed to raising SEK 25 million for healthtech company Braive as part of the company’s latest round, totalling SEK 30 million. Braive has developed an AI-based, clinically validated platform for mental health treatment that enables more efficient, scalable, and measurable care. The capital will fund further development of the company’s technology platform, preparations for expansion into new markets, and scaling of sales and marketing.
Mental health is one of the greatest global health challenges of our time, with fewer than one in ten people affected receiving the right support. At the same time, traditional therapy is resource-intensive and difficult to scale. Braive offers a digital mental health solution sold as a full platform to insurance companies and as a software platform for healthcare providers. The solution combines clinically validated cognitive behavioural therapy (CBT), diagnostic screenings, and AI-supported clinical tools.
The platform is used by both patients and clinicians, enabling efficient, scalable, and measurable treatment at a fraction of the cost of traditional therapy. Braive has also recently secured CE marking under EU MDR class IIa, strengthening the platform’s credibility as a medical device within mental health. The company’s customers include leading insurance companies and healthcare providers in Sweden and Norway.
The company’s shareholders include Sven Hagströmer’s investment company Bioinvestor, The Inner Foundation – founded by Annika Sten Pärson and Pär-Jörgen Pärson – as well as Norwegian firm Altitude Capital and a number of business angels.
“We look forward to following the company’s continued development. Braive operates in a large and fast-growing healthcare segment with a clinically and regulatorily validated, and commercially proven platform. The combination of growth, recurring revenues, and clear customer value makes Braive an attractive company,” says Andreas Lindblom, Managing Partner at Sciety.
“With the new capital, we look forward to continuing our growth journey. We are seeing strong interest in our solution and have a number of active dialogues with major healthcare operators and insurance companies in the Nordics, which form the foundation for continued growth and expansion,” says Hermine Bonde Jahren, CEO and founder of Braive.
For more information, please contact:
Andreas Lindblom, Managing Partner, Sciety: andreas.lindblom@sciety.se, tfn. +46 70 375 73 73
Hermine Bonde Jahren, CEO Braive, hermine@braive.com, tfn. +46 702 14 85 54
About Sciety
Sciety is a long-term investment partner and investor in life science and health tech, with a focus on the Nordic region. We identify and invest in growth companies with the potential to create significant value for both investors and society, and with a clear path towards a future exit. We lead investment processes and invest alongside leading venture capital firms, family offices, and through our investor network, Sciety Venture Partners. Our goal is for growth companies within life science and digital health to scale and succeed, making scientific breakthroughs in medicine and technology accessible to people all over the world. For more information, visit sciety.com and follow us LinkedIn.
About Braive
Braive is an AI-driven platform for evidence-based mental health treatment. The platform encompasses screening, assessment, digital therapy, AI-based clinical support, and structured outcome measurement. Braive is implemented across healthcare and insurance organisations in the Nordics and has been used by more than 100,000 patients. Braive Therapy is first in the world to receive EU MDR Class IIa certification for the full treatment journey in digital mental health. Read more at www.braive.com.
